These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16928853)

  • 1. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.
    Nadjar A; Brotchie JM; Guigoni C; Li Q; Zhou SB; Wang GJ; Ravenscroft P; Georges F; Crossman AR; Bezard E
    J Neurosci; 2006 Aug; 26(34):8653-61. PubMed ID: 16928853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
    Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
    Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Perez XA; Zhang D; Bordia T; Quik M
    Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
    Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
    Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diametric neural ensemble dynamics in parkinsonian and dyskinetic states.
    Parker JG; Marshall JD; Ahanonu B; Wu YW; Kim TH; Grewe BF; Zhang Y; Li JZ; Ding JB; Ehlers MD; Schnitzer MJ
    Nature; 2018 May; 557(7704):177-182. PubMed ID: 29720658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
    Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
    Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
    Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
    Deng YP; Lei WL; Reiner A
    J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
    Boraud T; Bezard E; Bioulac B; Gross CE
    Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct modulation of firing activity by dopamine D
    Zhu YC; Xue Y; Diao HL; Chen H; Liu HY; Han XH; Chen L
    Sheng Li Xue Bao; 2016 Oct; 68(5):699-707. PubMed ID: 27778037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB).
    Luquin N; Sierra S; Rico AJ; Gómez-Bautista V; Roda E; Conte-Perales L; Franco R; McCormick P; Labandeira-García JL; Lanciego JL
    Neurobiol Dis; 2012 Sep; 47(3):347-57. PubMed ID: 22659306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.
    Perreault ML; Hasbi A; Alijaniaram M; Fan T; Varghese G; Fletcher PJ; Seeman P; O'Dowd BF; George SR
    J Biol Chem; 2010 Nov; 285(47):36625-34. PubMed ID: 20864528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.
    Sano H; Yasoshima Y; Matsushita N; Kaneko T; Kohno K; Pastan I; Kobayashi K
    J Neurosci; 2003 Oct; 23(27):9078-88. PubMed ID: 14534241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
    Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
    Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.